• Japanese
  • Korean
  • Chinese
Cover Image

Impetigo Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Impetigo Global Clinical Trials Review, H1, 2015" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Impetigo
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Impetigo to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Impetigo to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Impetigo
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Impetigo Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • NovaBay Pharmaceuticals, Inc.
      • Clinical Trial Overview of NovaBay Pharmaceuticals, Inc.
      • The LEO Foundation
      • Clinical Trial Overview of The LEO Foundation
      • Nestle S.A.
      • Clinical Trial Overview of Nestle S.A.
      • Lytix Biopharma AS
      • Clinical Trial Overview of Lytix Biopharma AS
      • Ferrer Internacional S.A.
      • Clinical Trial Overview of Ferrer Internacional S.A.
      • Foamix Pharmaceuticals Ltd.
      • Clinical Trial Overview of Foamix Pharmaceuticals Ltd.
      • Dermal Laboratories Limited
      • Clinical Trial Overview of Dermal Laboratories Limited
      • Chiltern International Ltd.
      • Clinical Trial Overview of Chiltern International Ltd.
      • Ambria Dermatology AB (Inactive)
      • Clinical Trial Overview of Ambria Dermatology AB (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • Menzies School of Health Research
      • Clinical Trial Overview of Menzies School of Health Research
      • Beaumont Health System
      • Clinical Trial Overview of Beaumont Health System
      • Philippine Dermatological Society
      • Clinical Trial Overview of Philippine Dermatological Society
      • Royal North Shore Hospital
      • Clinical Trial Overview of Royal North Shore Hospital
      • University of Texas Health Science Center at Houston
      • Clinical Trial Overview of University of Texas Health Science Center at Houston
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Impetigo Therapeutics, Global, Clinical Trials by Region, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Impetigo to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Impetigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Impetigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Impetigo to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Impetigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Impetigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Impetigo Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Impetigo Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Impetigo Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by NovaBay Pharmaceuticals, Inc., 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Lytix Biopharma AS, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferrer Internacional S.A., 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Foamix Pharmaceuticals Ltd., 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Dermal Laboratories Limited, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Ltd., 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Ambria Dermatology AB (Inactive), 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Beaumont Health System, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Philippine Dermatological Society, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal North Shore Hospital, 2015*
  • Impetigo Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Health Science Center at Houston, 2015*

List of Figures

  • Impetigo Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Impetigo Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Impetigo Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Impetigo to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Impetigo Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Impetigo Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Impetigo to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Impetigo Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Impetigo Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Impetigo Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Impetigo Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Impetigo Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Impetigo Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top